Consistent with this, our present data showed that BPQDs treatment enhanced IR-induced lagging chromosomes and chromatin bridges in RCC cells, indicating that BPQDs may also influence HDAC6-HSP90 signaling via suppression of DNA-PKcs. The gene discussed is HDAC6; the disease is renal cell carcinoma.